Chittorgarh.com Logo
Loading...
Nov 21, 2022 - May 20, 2023

Windlas Biotech Limited Buyback (Windlas Biotech Buyback 2022) Detail

Incorporated in 1991, Windlas Biotech Limited is in the business of providing pharmaceutical services. The company manufactures solid and liquid pharmaceutical dosage forms and provides a comprehensive range of services and specialized capabilities that include product discovery, product development, licensing, and commercial manufacturing of generic products.

Windlas Biotech markets their own manufactured authentic nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities at affordable prices. The company is associated with more than 100 leading Domestic Pharmaceuticals/MNCs.

Windlas Biotech Buyback 2022 Detail

Issue PeriodNov 21, 2022 - May 20, 2023
Security NameWindlas Biotech Limited
Issue TypeOpen Market Through Stock Exchange
Issue Size (Amount)₹25.00 Crores
Buyback Price₹325 per share
Face Value₹5 per share
Listing AtBSE, NSE

Company Financials

Windlas Biotech Limited Financial Information (Restated)
Period EndedTotal RevenueProfit After TaxNet Worth
31-Mar-20331.3423.68209.66
31-Mar-21430.715.74199.12
31-Mar-22472.6438.09394.78
Amount in ₹ Crore

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2022 244.7 212.15 232.89
Jan-2022 261.2 219 241.72
Jan-2022 232.9 203.55 217.81

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2022 244.8 212 227.41
Jan-2022 261.9 216.3 241.83
Jan-2022 233.95 209.7 218.71

Necessity of the Issue

The buyback is being undertaken for the following reason:

1.To return surplus funds to the equity shareholders of the Company.

2. To improve return on equity, by reducing in equity base, thereby leading to a long-term increase in the value of shareholders.

Windlas Biotech Buyback 2022 Documents

Windlas Biotech Buyback 2022 Rating

7
4.7
Rating:Rated 4.7 stars
Vote Here ...

Windlas Biotech Buyback 2022 Reviews

Sorry, we couldn't find any reviews, please check back later.

Company Contact Information

Windlas Biotech Limited
705-706, Vatika Professional Point,
Sector-66
Golf Course Extension Road, Gurgaon,122001

Phone: +91-124-2821030
Email: grievance@windlasbiotech.com
Website: https://windlas.com/

Windlas Biotech Buyback 2022 Registrar

  1. Link Intime India Private Ltd
       Link Intime India Private Ltd
       C 101, 247 Park, L.B.S.Marg,
       Vikhroli (West), Mumbai - 400083

    Phone: +91-22-4918 6270
    Email: delhi@linkintime.co.in
    Website: https://linkintime.co.in/

Windlas Biotech Buyback 2022 Manager

Lead Manager(s)

  1. Corporate Professionals Capital Private Ltd

Registered Broker

  1. SMC Global Securities Limited
    Email: crf@smcindiaonline.com

Find Windlas Biotech Buyback 2022 Latest Update

Windlas Biotech Buyback 2022 FAQs

The Windlas Biotech Buyback 2022 opens on Nov 21, 2022, and closes on May 20, 2023.

The Windlas Biotech Buyback 2022 is a Open Market Through Stock Exchange.

Windlas Biotech Buyback 2022 Schedule

Buyback Opening DateNov 21, 2022
Buyback Closing DateMay 20, 2023
Last date for acceptance of sharesUpon relevant pay-out by the Stock exchange

The Windlas Biotech Buyback 2022 is being offered at Rs ₹325 per share per equity share.

There is no ratio applicable in case of open market offer through stock exchange mechanism.

There is no concept of record date in case of open market through stock exchange mechanism.

The Windlas Biotech Buyback 2022 has announced a buyback for an aggregate amount of not more than Rs. ₹25.00 Crores with pricing of Rs.₹325 per share.

The buyback is being undertaken for the following reason:

1.To return surplus funds to the equity shareholders of the Company.

2. To improve return on equity, by reducing in equity base, thereby leading to a long-term increase in the value of shareholders.

Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.

The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.

The Windlas Biotech Buyback 2022 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.


1 Comments

1. Bharatkumar Patel   I Like It. |Report Abuse|  Link|Dec 3, 2022 11:01:08 AMReply
this company issue shares through IPO in 2021 price was 460/- per share. and buyback offer is lesser then IPO price